FRA/PFEB (FRA/PFEB)

Frankfurt Stock Exchange: FRA/PFEB · EUR

€8.30

+0.10 (+1.2%)· Recorded snapshot

Market cap	152.4B
Revenue (ttm)	55.8B
Net income (ttm)	3.8B
EPS (ttm)	€0.17
P/E (trailing)	48.6x
P/E (forward)	10.4x
Dividend	€0.48 (5.75%)
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 55.8B
Net income (ttm): 3.8B
EPS (ttm): €0.17
P/E (trailing): 48.6x
P/E (forward): 10.4x
Market cap: 152.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.4

P25 n/aP50 n/aP75 n/a

Trailing P/E48.6

P25 n/aP50 n/aP75 n/a

ROE5

P25 n/aP50 n/aP75 n/a

ROIC13.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FRA/PFEB indicators

Market & fundamental data

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-11-03
Employees	75,000
Employees change	-7,000
Employees growth	-7.95%
Enterprise value	EUR 199.2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
Financial report date	2026-06-28
First seen	2026-05-10
Fiscal year end	December
Founded	1849
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CA7170651060
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Market cap	EUR 152.4B
Next earnings date	2026-11-03
Price	EUR 8.30
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	fra/PFEB
Website	https://www.pfizer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	18.97x
Average P/E ratio (3Y)	26.74x
Average P/E ratio (5Y)	19.53x
Earnings yield	2.06%
EV/Earnings	52.42x
EV/EBIT	11.78x
EV/EBITDA	8.44x
EV/FCF	20.68x
EV/Sales	3.48x
FCF / EV yield	4.84%
FCF yield	6.32%
Forward P/E	10.42x
Graham number	4.35889
Graham upside	-47.48%
Lynch fair value	EUR 1.03
Lynch upside	-87.54%
P/(FCF - SBC) ratio	17.32x
P/(OCF - SBC) ratio	13.96x
P/B ratio	2.03x
P/E ratio	48.6x
P/FCF ratio	15.83x
P/OCF ratio	12.97x
P/S ratio	2.73x
Price/EBITDA ratio	6.85x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	29.58%
EBITDA margin	39.85%
FCF margin	16.82%
Gross margin	74.72%
Operating margin	29.58%
Pretax margin	6.61%
Profit margin	6.8%
Profit per employee	EUR 50,667
Profitable years	35
Revenue per employee	EUR 744,649
ROA	5.78%
ROA (5Y)	7.03%
ROCE	11.18%
ROE	5.01%
ROE (5Y)	17.68%
ROIC	13.49%
ROIC (5Y)	18.62%
SBC / revenue	1.49%
Tax / revenue	-0.26%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-59.88%
EPS growth 10Y	-3.88%
EPS growth 3Y	-41.3%
EPS growth 5Y	-19.56%
EPS growth years	0
FCF growth	-11.68%
FCF growth (QoQ)	-86.14%
FCF growth 3Y	0.99%
FCF growth 5Y	-12.27%
Gross profit growth	2.68%
Gross profit growth (Q)	2.04%
Gross profit growth 3Y	-4.76%
Gross profit growth 5Y	3.85%
Net income growth	-59.69%
Net income growth 3Y	-41.34%
Net income growth 5Y	-19.42%
Net income growth years	0
OCF growth	-11.77%
OCF growth (QoQ)	-68.07%
OCF growth 10Y	-1.34%
OCF growth 3Y	-2.73%
OCF growth 5Y	-10.66%
Operating income growth	11.09%
Operating income growth (Q)	-0.31%
Operating income growth 3Y	-10.2%
Operating income growth 5Y	5.06%
Revenue growth	-0.21%
Revenue growth (Q)	2.6%
Revenue growth (QoQ)	4.03%
Revenue growth 10Y	1.99%
Revenue growth 3Y	-6.7%
Revenue growth 5Y	2.93%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -2.1B
Depreciation and amortization	EUR 5.9B
EBIT	EUR 16.5B
EBITDA	EUR 22.3B
EPS	EUR 0.17
Financing cash flow	EUR -7.4B
Free cash flow	EUR 9.6B
Free cash flow minus SBC	EUR 8.8B
Gross profit	EUR 41.7B
Income taxes	EUR -143.8M
Investing cash flow	EUR -5B
Net borrowing	EUR 1.6B
Net cash flow	EUR -578.7M
Net income	EUR 3.8B
Operating cash flow minus SBC	EUR 10.9B
Operating income	EUR 16.5B
Revenue	EUR 55.8B
Stock-based compensation	EUR 830.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.22
Book value per share	EUR 13.11
Debt / EBITDA	2.41
Debt / equity	0.74
Debt / FCF	5.78
Goodwill	EUR 64.2B
Interest coverage	6.98
Long-term assets	EUR 139.2B
Long-term liabilities	EUR 72B
Net cash (debt)	EUR -45.4B
Net cash / market cap	-29.78%
Net debt / EBITDA	2.04
Net debt / equity	0.61
Net debt / FCF	4.71
Piotroski F-Score	7
Property, plant and equipment	EUR 17.1B
Shareholders' equity	EUR 75B
Tangible book value	EUR -29.2B
Tangible book value per share	EUR -5.12
Total assets	EUR 176.4B
Total cash	EUR 10.3B
Total debt	EUR 55.7B
Total liabilities	EUR 101.4B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.31
Current assets	EUR 37.2B
Current liabilities	EUR 29.3B
Current ratio	1.27
Inventory turnover	1.49
Net working capital	EUR -249M
Quick ratio	0.85
Working capital	EUR 7.6B
Working capital turnover	7.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.34%
Dividend growth	-3.84%
Dividend growth (3Y)	-3.39%
Dividend growth years	0
Dividend payment date	2026-12-14
Dividend payment years	4
Dividend payout frequency	Quarterly
Dividend per share	EUR 0.48
Dividend yield	5.75%
Ex-dividend date	2026-11-06
Last dividend	EUR 0.12
Payout ratio	225.77%
Shareholder yield	5.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 7.22
1D price change	1.22%
1M price change	8.5%
1M total return	8.5%
1W price change	-1.19%
1W total return	-1.19%
1Y price change	24.81%
1Y return CAGR	33.86%
1Y total return	33.83%
20-day SMA	EUR 7.85
200-day SMA	EUR 7.22
3M price change	27.69%
3M total return	27.69%
3Y price change	-14.87%
3Y return CAGR	1.18%
3Y total return	3.57%
50-day SMA	EUR 7.67
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 8.50
52-week high date	2026-10-16
52-week low	EUR 5.80
52-week low date	2025-12-03
6M price change	13.7%
6M total return	17.76%
All-time high	EUR 19.40
All-time high date	2022-07-11
All-time low	EUR 5.80
All-time low date	2025-12-03
Average true range (ATR)	EUR 0.16
Average volume	86.7
Change from 52-week high	-2.35%
Change from 52-week low	43.1%
Change from all-time high	-57.22%
Change from all-time low	43.1%
Change from open	1.84%
Day's gap	-0.61%
High price	EUR 8.30
Low price	EUR 8.15
Monthly RSI	54.71
Open price	EUR 8.15
Position in 52-week range	100%
Previous close	EUR 8.20
Price vs 150-day SMA	14.94%
Price vs 20-day SMA	5.73%
Price vs 200-day SMA	14.94%
Price vs 50-day SMA	8.27%
Relative volume	9.73
RSI	62.73
Sharpe ratio	0.8
Sharpe ratio (3Y)	0.16
Sortino ratio	1.35
Sortino ratio (3Y)	0.38
Volume	0
Weekly RSI	65.59
YTD price change	23.88%
YTD total return	30.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5.7B
Shares change (QoQ)	-0.56%
Shares change (YoY)	0.34%
Shares held by insiders	0.03%
Shares held by institutions	68.07%
Short ratio	4 days

Deeper analysis on FRA/PFEB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRA/PFEB report

Is a complete FRA/PFEB research report available?

No complete published report is available for fra/PFEB (FRA/PFEB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/PFEB (FRA/PFEB)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/PFEB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/PFEB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/PFEB

Frequently asked questions